Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether he has made an assessment of the cost effectiveness of HIV PeEP if only given to a very small group of high-risk individuals.

The National Institute for Health and Care Excellence is developing an evidence summary on the use of Truvada for Pre-exposure prophylaxis that is expected to be published in the autumn. The evidence summary will consider the evidence for effectiveness, safety, patient factors and resource implications including cost.